Company Filing History:
1 out of 167 
1 out of 189 Years Active: 2020
Title: The Innovative Contributions of Sebastian Trousil
Introduction
Sebastian Trousil is a notable inventor based in London, GB. He has made significant contributions to the field of medical imaging and cancer monitoring through his innovative work. His research focuses on the development of polypeptides that can be utilized for imaging and monitoring tumors and cancers.
Latest Patents
Sebastian Trousil holds a patent for "HER2 polypeptides useful for imaging and monitoring tumors and cancers." This patent describes a method of using an isolated polypeptide conjugated with a radionuclide. The isolated polypeptide specifically binds to HER2 or its variants. The method is designed for monitoring the response to HSP90 inhibition and involves the use of the isolated polypeptide conjugated with 18F. Additionally, the application outlines the use of this isolated polypeptide as an imaging agent to monitor uptake and measure HSP90 inhibition.
Career Highlights
Throughout his career, Trousil has worked with prominent companies such as Imperial Innovations Limited and GE Healthcare Limited. His experience in these organizations has allowed him to contribute to advancements in medical technology and cancer treatment.
Collaborations
Sebastian Trousil has collaborated with notable professionals in his field, including Duncan Robert R Hiscock and Eric Ofori Aboagye. These collaborations have further enhanced his research and development efforts.
Conclusion
Sebastian Trousil's innovative work in the field of medical imaging and cancer monitoring has made a significant impact. His contributions through patents and collaborations highlight the importance of research in advancing healthcare solutions.